Chief Executive Officer (CEO)
Curtis Head co-founded PRC Clinical in 2003. As CEO and board member, he is leading and expanding PRC Clinical’s brand, growth, and services in the United States and beyond.
Curtis has 20 years of clinical research experience from academia to pharmaceutical and Contract Research Organizations (CROs) focused in neurology, immunology, pulmonary and cardiovascular. Prior to co-founding PRC Clinical, Curtis was Vice President at Relevare Pharmaceuticals where he coordinated the efforts of outsourcing and managing clinical drug development. His focus was the development of accelerated parallel strategies for international agencies and US IND filings. In addition to working in North America, Curtis has supported Sponsors and clinical studies in Europe, Latin America, Australia and India.
Curtis’ education and interests are in Health Science, Law, Public Policy and Ethics. Previously, Curtis earned a degree in Information Technology (IT) and lectured for San Francisco State University’s Clinical Trials Design and Management course on the topics of outsourcing, contracts & budgets and CRO Management.